Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Autoimmunity has long been linked to myocarditis and its sequela, dilated cardiomyopathy, the leading causes of heart failure in young patients. However, the underlying mechanisms are poorly defined, with most clinical investigations focused on humoral autoimmunity as the target for intervention. Here, we show that the α-isoform of myosin heavy chain (α-MyHC, which is encoded by the gene Myh6) is the pathogenic autoantigen for CD4+ T cells in a spontaneous mouse model of myocarditis. Further, we found that Myh6 transcripts were absent in mouse medullary thymic epithelial cells (mTECs) and peripheral lymphoid stromal cells, which have been implicated in mediating central and peripheral T cell tolerance, respectively. Transgenic expression of α-MyHC in thymic epithelium conferred tolerance to cardiac myosin and prevented myocarditis, demonstrating that α-MyHC is a primary autoantigen in this disease process. Remarkably, we found that humans also lacked α-MyHC in mTECs and had high frequencies of α-MyHC-specific T cells in peripheral blood, with markedly augmented T cell responses to α-MyHC in patients with myocarditis. Since α-MyHC constitutes a small fraction of MyHC in human heart, these findings challenge the longstanding notion that autoimmune targeting of MyHC is due to its cardiac abundance and instead suggest that it is targeted as a result of impaired T cell tolerance mechanisms. These results thus support a role for T cell-specific therapies for myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Animal models of myocarditis have yielded a wealth of information about the pathogenesis of disease including a number of landmark articles that demonstrate that myocarditis is an autoimmune disease that requires TLR activation by microbes. 44,152,153”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [153]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that α -MyHC is expressed in both the atrium and ventricle of mouse hearts”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies on autoreactive cardiac myosin-specific T cells indicated that they escape negative selection in the thymus and can be found in circulation as well as in naive hearts, marked by CD69 expression, a well-known marker for tissue residency in T cells. 42,47”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“autoreactive T cells that recognize α -MyHC naturally develop in every individual”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“T cells specific for α -MyHC were identified as self-antigen-recognizing T-cell clones that escape thymic negative selection, migrate to the heart, and trigger autoimmune myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [47]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
Lipshultz, S. E., Sleeper, L. A., Towbin, J. A., Lowe, A. M., Orav, E. J., Cox, G. F., Lurie, P. R., McCoy, K. L., McDonald, M. A., Messere, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021715 · Cited by 890
Mann, D. L., Zipes, D. P., Libby, P., Bonow, R. O., & D, E. B. M. (2015) · Elsevier eBooks · Cited by 882
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809
The Epidemiology of Childhood Cardiomyopathy in Australia
Nugent, A. W., Daubeney, P. E. F., Chondros, P., Carlin, J. B., Cheung, M., Wilkinson, L. C., Davis, A. M., Kahler, S. G., Chow, C. W., Wilkinson, J. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021737 · Cited by 785
A CENTRAL ROLE FOR CENTRAL TOLERANCE
Kyewski, B., & Klein, L. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115601 · Cited by 748
Self-citationFrustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604
Cited by
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)
Klein, L., Kyewski, B., Allen, P. M., & Hogquist, K. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3667 · Cited by 1,383
Self-citationde Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
Hofmann, U., Beyersdorf, N., Weirather, J., Podolskaya, A., Bauersachs, J., Ertl, G., Kerkau, T., & Frantz, S. (2012) · Circulation · doi:10.1161/circulationaha.111.044164 · Cited by 471
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
T cells specific for α-myosin drive immunotherapy-related myocarditis
Axelrod, M. L., Meijers, W. C., Screever, E. M., Qin, J., Carroll, M. G., Sun, X., Tannous, E., Zhang, Y., Sugiura, A., Taylor, B. C., et al. (2022) · Nature · doi:10.1038/s41586-022-05432-3 · Cited by 367
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
Li, J., Tan, J., Martino, M. M., & Lui, K. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00585 · Cited by 344
“Moreover, the cardiomyocyte-specific protein, α-myosin heavy chain (αMHC), is not expressed within the thymus of mice and human, and it resembles a non-self protein that activates CD4+ T-cells after MI (70).”
BackgroundRole of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction
Hofmann, U., & Frantz, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.304072 · Cited by 296
“A key paper recently ascribed an outstanding immunologic function to the cardiac protein α-MyHC, which is encoded by the gene Myh6.”
BackgroundInfluentialLeft Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure
Nevers, T., Salvador, A. M., Grodecki-Pena, A., Knapp, A., Velázquez, F., Aronovitz, M., Kapur, N. K., Karas, R. H., Blanton, R. M., & Alcaide, P. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002225 · Cited by 274
Culina, S., Lalanne, A. I., Afonso, G., Cerosaletti, K., Pinto, S., Sebastiani, G., Kuranda, K., Nigi, L., Eugster, A., Østerbye, T., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao4013 · Cited by 264
Self-citationMicrobiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., et al. (2019) · Science · doi:10.1126/science.aav3487 · Cited by 260
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237
“Why would these antigens slip through the central and peripheral mechanisms that promote tolerance to self? While, in most cases, cause-and-effect relationships remain unclear (136), this question has been explored for α-myosin heavy chain (166).”
BackgroundCardiac Autoimmunity: Myocarditis
Bracamonte-Baran, W., & Čiháková, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-57613-8_10 · Cited by 228
Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling
Santos-Zas, I., Lemarié, J., Zlatanova, I., Cachanado, M., Seghezzi, J.-C., Benamer, H., Goube, P., Vandestienne, M., Cohen, R., Ezzo, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21737-9 · Cited by 202
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Thymic epithelial cell heterogeneity: TEC by TEC
Kadouri, N., Nevo, S., Goldfarb, Y., & Abramson, J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0238-0 · Cited by 191
Autoantibodies in Heart Failure and Cardiac Dysfunction
Kaya, Z., Leib, C., & Katus, H. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243360 · Cited by 187
Myocarditis in Humans and in Experimental Animal Models
Błyszczuk, P. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00064 · Cited by 161
Nindl, V., Maier, R., Ratering, D., De Giuli, R., Züst, R., Thiel, V., Scandella, E., Di Padova, F., Kopf, M., Rudin, M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142209 · Cited by 141
Won, T., Kalinoski, H. M., Wood, M. K., Hughes, D. M., Jaime, C. M., Delgado, P., Talor, M. V., Lasrado, N., Reddy, J., & Čiháková, D. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111611 · Cited by 137
Myocardial Infarction Primes Autoreactive T Cells through Activation of Dendritic Cells
Van der Borght, K., Scott, C. L., Nindl, V., Bouché, A., Martens, L., Sichien, D., Van Moorleghem, J., Vanheerswynghels, M., De Prijck, S., Saeys, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.079 · Cited by 130
“Because aMyHC autoreactive CD4+ T cells escape from the thymus into the periphery (Lv et al., 2011), it is plausible that cardiac DCs would function in preserving peripheral tolerance to the heart.”
InfluentialT cell checkpoint regulators in the heart
Grabie, N., Lichtman, A. H., & Padera, R. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz025 · Cited by 123
T-cell recruitment to the heart: friendly guests or unwelcome visitors?
Blanton, R. M., Carrillo-Salinas, F. J., & Alcaide, P. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00028.2019 · Cited by 121
Sousa, G. R., Pober, D., Galderisi, A., Lv, H., Yu, L., Pereira, A. C., Doria, A., Kosiborod, M., & Lipes, M. A. (2019) · Circulation · doi:10.1161/circulationaha.118.036068 · Cited by 117
Self-citationImmune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
Caforio, A. L. P., Marcolongo, R., Jahns, R., Fu, M. L. X., Felix, S. B., & Iliceto, S. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9364-5 · Cited by 118
Seropian, I. M., Cerliani, J. P., Toldo, S. A., Tassell, B. W. V., Ilarregui, J. M., Gonzalez, G. E., Matoso, M., Salloum, F. N., Melchior, R. D., Gelpi, R. J., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.022 · Cited by 120
Marx, A., Yamada, Y., Simon‐Keller, K., Schalke, B. C. G., Willcox, N., Ströbel, P., & Weis, C. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00842-3 · Cited by 131
Clinical presentation and diagnosis of myocarditis
Caforio, A. L. P., Marcolongo, R., Basso, C., & Iliceto, S. (2015) · Heart · doi:10.1136/heartjnl-2014-306363 · Cited by 107
T cells specific for post-translational modifications escape intrathymic tolerance induction
Raposo, B., Merky, P., Lundqvist, C., Yamada, H., Urbonaviciute, V., Niaudet, C., Viljanen, J., Kihlberg, J., Kyewski, B., Ekwall, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02763-y · Cited by 92
Self-citationImmune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
Munir, A. Z., Gutierrez, A., Qin, J., Lichtman, A. H., & Moslehi, J. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00715-5 · Cited by 101
“Central tolerance is known to be inadequate in preventing cardiac autoimmunity, failing to eliminate T cells that recognize certain cardiac antigens 20 .”
InfluentialOnder, L., Nindl, V., Scandella, E., Chai, Q., Cheng, H., Firner, S., Novković, M., Bomze, D., Maier, R., Mair, F., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545677 · Cited by 105
Immune responses in checkpoint myocarditis across heart, blood and tumour
Blum, S. M., Zlotoff, D. A., Smith, N. P., Kernin, I., Ramesh, S., Zubiri, L., Caplin, J., Samanta, N., Martin, S., Wang, M., et al. (2024) · Nature · doi:10.1038/s41586-024-08105-5 · Cited by 114
“We then investigated whether heart-expanded TCRs are specific for the previously described cardiac autoantigens α-myosin 16 , troponin I and troponin T 29–31 .”
The heart of the matter: Protection of the myocardium from T cells
Lichtman, A. H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.004 · Cited by 96
“Subsequently, this lymph node has been shown to be the site of expansion of α-myosin heavy chain specific CD4+ T cells in spontaneous and post-infarction models of myocarditis in NOD mice [10, 12, 24].”
BackgroundLee, W.-S., Erdelyi, K., Matyas, C., Mukhopadhyay, P., Varga, Z. V., Liaudet, L., Haskó, G., Čiháková, D., Mechoulam, R., & Pacher, P. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00007 · Cited by 84
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02591-2 · Cited by 83
Bronchus-associated Lymphoid Tissue in Pulmonary Hypertension Produces Pathologic Autoantibodies
Colvin, K. L., Cripe, P. J., Ivy, D. D., Stenmark, K. R., & Yeager, M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0403oc · Cited by 87
Waliany, S., Lee, D., Witteles, R. M., Neal, J. W., Nguyen, P., Davis, M. M., Salem, J.-E., Wu, S. M., Moslehi, J. J., & Zhu, H. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023451 · Cited by 76
Pinto, S., Michel, C., Schmidt‐Glenewinkel, H., Harder, N., Rohr, K., Wild, S., Brors, B., & Kyewski, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308311110 · Cited by 80
Self-citationMyocardial Infarction Triggers Chronic Cardiac Autoimmunity in Type 1 Diabetes
Gottumukkala, R. V. S. R. K., Lv, H., Cornivelli, L., Wagers, A. J., Kwong, R. Y., Bronson, R., Stewart, G. C., Schulze, P. C., Chutkow, W., Wolpert, H. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003551 · Cited by 76
Self-citationNew Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
Khunger, A., Battel, L., Wadhawan, A., More, A., Kapoor, A., & Agrawal, N. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00925-8 · Cited by 80
Immune checkpoint inhibitor-related myocarditis
Tajiri, K., Aonuma, K., & Sekine, I. (2017) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyx154 · Cited by 73
“reported that transcripts for heart-specific myosin heavy chain α isoform (MyHC-α) were absent in both mouse and human medullary thymic epithelial cells and that MyHC-α reactive T cells were markedly more abundant in myocarditis mice and patients (18).”
BackgroundRegulatory Role of CD4+T Cells in Myocarditis
Vdovenko, D., & Eriksson, U. (2018) · Journal of Immunology Research · doi:10.1155/2018/4396351 · Cited by 69
“Accordingly, patients with inflammatory cardiomyopathy demonstrate increased T cell responses against α-MyHC [28].”
BackgroundHaghikia, A., Kaya, Z., Schwab, J., Westenfeld, R., Ehlermann, P., Bachelier, K., Öttl, R., von Kaisenberg, C. S., Katus, H. A., Bauersachs, J. K., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0517-2 · Cited by 71
Wang, C., Lin, J., Wang, Y., Hsi, D. H., Chen, J., Liu, T., Zhou, Y., Ren, Z., Zeng, Z., Cheng, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770631 · Cited by 65
“Suggested possibilities include shared antigens between the tumor and myocardium, T-cell receptor targeting homologous muscle antigen as the tumor antigen, or certain T-cell receptors targeting dissimilar antigens (Lv et al., 2011; Johnson et al., 2016; Khunger et al., 2020).”
BackgroundVergès, B. L. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.06.005 · Cited by 79
Immune cells in cardiac repair and regeneration
Simões, F. C., & Riley, P. R. (2022) · Development · doi:10.1242/dev.199906 · Cited by 71
Shirafkan, F., Hensel, L., & Rattay, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1339714 · Cited by 77
The why and how of adaptive immune responses in ischemic cardiovascular disease
Mallat, Z., & Binder, C. J. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00049-1 · Cited by 72
The Role of Dendritic Cells in Central Tolerance
Oh, J., & Shin, J. (2015) · Immune Network · doi:10.4110/in.2015.15.3.111 · Cited by 66
“However, not every tissue-restricted antigen is expressed in mTECs (13), and even among those expressed, some are not effectively presented by mTECs (14).”
BackgroundAdaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling
Santos‐Zas, I., Lemarie, J., Tedgui, A., & Ait‐Oufella, H. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00198 · Cited by 64
“have reported that α-MyHC expression was not detectable in human thymus, a critical step to induce tolerance, and consequently α-MyHC–specific T-cells were found in the blood from healthy subjects (48).”
BackgroundMyocardial Milieu Favors Local Differentiation of Regulatory T Cells
Delgobo, M., Weiß, E., Ashour, D., Richter, L., Popiolkowski, L., Arampatzi, P., Stangl, V., Arias-Loza, P., Mariotti-Ferrandiz, E., Rainer, P. P., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.322183 · Cited by 57
Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
Jo, W., Won, T., Daoud, A., & Čiháková, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1340373 · Cited by 55
T cells in cardiac health and disease
Martín, P., & Sánchez‐Madrid, F. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185218 · Cited by 65
“This study corroborated these findings in humans, in which patients with myocarditis showed elevated frequencies of α -MyHC–specific T cells in peripheral blood (27).”
Tenascin-C in Heart Diseases—The Role of Inflammation
Imanaka‐Yoshida, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115828 · Cited by 57
Ucar, O., Tykocinski, L., Dooley, J., Liston, A., & Kyewski, B. (2013) · European Journal of Immunology · doi:10.1002/eji.201343343 · Cited by 52
Self-citationAutoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51
“47,280,281 Following ICI therapy, 40% of patients with myocarditis experience concomitant myositis, confirmed in mouse models.”
InfluentialKania, G., Siegert, S., Behnke, S., Prados-Rosales, R., Casadevall, A., Lüscher, T. F., Luther, S. A., Kopf, M., Eriksson, U., & Blyszczuk, P. (2013) · Circulation · doi:10.1161/circulationaha.112.000434 · Cited by 51
“Heart-specific autoimmunity is a consequence of the lack of T-cell tolerance to heart-specific α-myosin heavy chain (α-MyHC) in mice and in humans.(1,2) Activation of pattern-recognition receptors on innate immune cells is widely believed to control the development of autoimmunity.”
BackgroundThe Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology
Meier, L. A., & Binstadt, B. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00911 · Cited by 53
Pinto, S., Sommermeyer, D., Michel, C., Wilde, S., Schendel, D. J., Uckert, W., Blankenstein, T. J. F., & Kyewski, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201444499 · Cited by 49
Self-citationForte, E., Panahi, M., Baxan, N., Ng, F. S., Boyle, J. J., Branca, J. A., Bedard, O., Hasham, M. G., Benson, L., Harding, S. E., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15937 · Cited by 59
Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
Jiménez-Alejandre, R., Ruiz‐Fernández, I., & Martín, P. (2022) · Cancers · doi:10.3390/cancers14184494 · Cited by 50
“revealed the presence of T cells in the periphery reactive to the MyHCα and demonstrated that the cause is a lack of representation of this antigen in the mTECs of mice and humans [82].”
BackgroundHealing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
Wagner, M. J., Khan, M., & Mohsin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00639 · Cited by 52
“Several of these antigens have been linked to proteins associated with the cardiomyocyte, specifically cardiac troponin I and myosin heavy chain (102, 115).”
BackgroundExcess Cardiovascular Risk in Type 1 Diabetes Mellitus: Role for a Dysfunctional Immune Response?
Petrie, J., & Sattar, N. (2019) · Circulation · doi:10.1161/circulationaha.118.038137 · Cited by 39
Transcriptomic diversity in human medullary thymic epithelial cells
Carter, J. A., Strömich, L., Peacey, M., Chapin, S. R., Velten, L., Steinmetz, L. M., Brors, B., Pinto, S., & Meyer, H. V. (2022) · Nature Communications · doi:10.1038/s41467-022-31750-1 · Cited by 45
Self-citationCOVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
Giannotta, G., Murrone, A., & Giannotta, N. (2023) · Vaccines · doi:10.3390/vaccines11040747 · Cited by 51
Priorities in Cardio-Oncology Basic and Translational Science
Salloum, F. N., Tocchetti, C. G., Ameri, P., Ardehali, H., Asnani, A. H., de Boer, R. A., Burridge, P. W., Cabrera, J. Á., de Castro, J., Córdoba, R., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.08.003 · Cited by 49
Van der Borght, K., Scott, C. L., Martens, L., Sichien, D., Van Isterdael, G., Nindl, V., Saeys, Y., Boon, L., Ludewig, B., Gillebert, T. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02714 · Cited by 42
The double burden: type 1 diabetes and heart failure—a comprehensive review
Julián, M. T., de, A. P.-M., Julve, J., & Alonso, N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02136-y · Cited by 55
“Previous experimental studies have shown that the immune system is normally enriched in autoreactive CD4 + T cells specific for cardiac myosin due to loss of immunological tolerance [89].”
BackgroundDiretriz de Miocardites da Sociedade Brasileira de Cardiologia – 2022
Montera, M. W., Marcondes‐Braga, F. G., Simões, M. V., Moura, L. Z., Fernandes, F., Mangini, S., de Oliveira, A. C., de Souza, A. L. A. D. A. G., Ianni, B. M., Rochitte, C. E., et al. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220412 · Cited by 101
Role of Impaired Central Tolerance to α-Myosin in Inflammatory Heart Disease
Lv, H., & Lipes, M. A. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.07.005 · Cited by 41
“Our recent studies showing lack of central tolerance to α-myosin may provide an explanation for the preferential T cell targeting of α-myosin in EAM and CB3 myocarditis (Lv et al., 2011, Gottumukkala et al., 2012).”
BackgroundSelf-citationGröschel, C., Sasse, A., Röhrborn, C., Monecke, S., Didié, M., Elsner, L., Kruse, V., Bunt, G., Lichtman, A. H., Toischer, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16147-1 · Cited by 43
Kalinoski, H. M., Daoud, A. R., Rusinkevich, V., Jurčová, I., Talor, M. V., Welsh, R. A., Hughes, D., Zemanová, K., Stříž, I., Hooper, J. E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2323052121 · Cited by 44
“Autoreactive MyHC T cells were shown to escape negative selection in the thymus (32).”
InfluentialDeBerge, M., Zhang, S., Glinton, K. E., Grigoryeva, L., Hussein, I., Vorovich, E., Ho, K. J., Luo, X., & Thorp, E. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01428 · Cited by 42
“This is due in part to a lack of central tolerance to cardiac antigens (163), and impaired efferocytosis in individuals susceptible to type I diabetes.”
BackgroundProfound tumor-specific Th2 bias in patients with malignant glioma
Shimato, S., Maier, L. M., Maier, R., Bruce, J. N., Anderson, R. C. E., & Anderson, D. E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-561 · Cited by 35
Perez-Shibayama, C., Gil-Cruz, C., Cadosch, N., Lütge, M., Cheng, H.-W., De Martin, A., Frischmann, K., Joachimbauer, A., Onder, L., Papadopoulou, I., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00432-0 · Cited by 35
“…affected by the inflammation in One of the major causes underlying tissue damage during human myocarditis is the generation of autoimmune T cell responses against major histocompatibility complex (MHC) class II-binding peptides derived from the contractile protein myosin heavy chain 6 (MYH6) 7,8 .”
Tsuruoka, K., Wakabayashi, S., Morihara, H., Matsunaga, N., Fujisaka, Y., Goto, I., Imagawa, A., & Asahi, M. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.04.033 · Cited by 36
Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation
Zhang, X., & Reinsmoen, N. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00434 · Cited by 35
“The thymus of mice and humans does not express myosin heavy chain proteins, thus CD4+ T cells are not negatively selected for myosin in the maturation process (40).”
BackgroundUccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
Wang, D., Bauersachs, J. K., & Berliner, D. (2023) · Biology · doi:10.3390/biology12030472 · Cited by 41
“Furthermore, impaired negative selection of CD4+ T-cells specific for the alpha-myosin heavy chain in the thymus of mice and humans has led to the development of myocarditis [92].”
BackgroundControl of inflammatory heart disease by CD4+ T cells
Barin, J. G., & Čiháková, D. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12134 · Cited by 34
The thymus and the science of self
Geenen, V. G. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-020-00831-y · Cited by 37
Rate and patient features associated with recurrence of acute myocarditis
Kytö, V., Sipilä, J., & Rautava, P. T. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.11.001 · Cited by 35
“Susceptibility to viral myocarditis varies significantly between different murine strains [18] and genetic predispositions to myocarditis [19] and its sequel dilated cardiomyopathy [20], have also been detected in humans, suggesting that patients with recurrencemay be genetically susceptible for acquiring myocarditis…”
BackgroundNiche competition and cancer metastasis to bone
Schuettpelz, L. G., & Link, D. C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57229 · Cited by 38
Identification of MYH6 as the potential gene for human ischaemic cardiomyopathy
Chen, J., Wang, L., Tao, L., Qi, B., Wang, Y., Guo, Y., & Miao, L. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17015 · Cited by 29
Geenen, V. G., Bodart, G., Henry, S., Michaux, H., Dardenne, O., Charlet-Renard, C., Martens, H., & Hober, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00187 · Cited by 32
Rakisheva, A., Farmakis, D. T., Attanasio, A. F., Bayés‐Genís, A., Solal, A. C., Gulati, G., Halle, M., Hill, L., López‐Fernández, T., Lyon, A. R., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3753 · Cited by 41
Monocytes prime autoreactive T cells after myocardial infarction
DeBerge, M., Yu, S., Dehn, S., Ifergan, I., Yeap, X. Y., Filipp, M. E., Becker, A., Luo, X., Miller, S. D., & Thorp, E. B. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00595.2019 · Cited by 29
Crnkovic, M. Z., Kania, G., Jaźwa, A., Czepiel, M., Wijnen, W. J., Czyż, J., Müller‐Edenborn, B., Vdovenko, D., Lindner, D., Gil‐Cruz, C., et al. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0766-6 · Cited by 30
Dong, H., Qi, Y., Kong, X., Wang, Z., Fang, Y., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.835510 · Cited by 34
“, have found that protein α-isoform of myosin heavy chain (α-MyHC, a kind of cardiac antigen) encoded by Myb6 let mice and humans receive the immune tolerance with the help of medullary thymic epithelial cells (mTECs) and peripheral lymphoid stromal cells, preventing from T-lymphocyte infiltration myocarditis (Lv et a…”
BackgroundHeart macrophages and dendritic cells in sickness and in health: A tale of a complicated marriage
der Borght, K. V., & Lambrecht, B. N. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.011 · Cited by 29
Gong, J., Neilan, T. G., & Zlotoff, D. A. (2023) · Immunological Reviews · doi:10.1111/imr.13240 · Cited by 30
Xu, L., Chen, Y., Xiong, L., Shen, Y., Zhou, Z., Wang, S., & Xu, X. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2512645 · Cited by 36
“67,68 α-MyHC is also the most commonly used drug in the creation of auto-immune myocarditis models.”
Role of the Lymphatics in Cardiac Disease
Cooper, S. T. E., Lokman, A. B., & Riley, P. R. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319854 · Cited by 27
Nishijima, H., Kajimoto, T., Matsuoka, Y., Mouri, Y., Morimoto, J. O., Matsumoto, M., Kawano, H., Nishioka, Y., Uehara, H., Izumi, K., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.09.006 · Cited by 26
Zempo, H., Sugita, Y., Ogawa, M., Watanabe, R., Suzuki, J., & Isobe, M. (2014) · Heart and Vessels · doi:10.1007/s00380-014-0527-2 · Cited by 27
The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction
O’Donohoe, T. J., Schrale, R. G., & Ketheesan, N. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.035 · Cited by 26
Chen, X., Zeng, X., Wang, M., Chen, L., Zhang, N., Rao, M., Yang, P., & Song, J. (2018) · Circulation · doi:10.1161/circulationaha.118.033890 · Cited by 24
Mitochondrial extracellular vesicles, autoimmunity and myocarditis
Florio, D. N. D., Beetler, D. J., McCabe, E. J., Sin, J., Ikezu, T., & Fairweather, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374796 · Cited by 30
Akiyama, T., Shinzawa, M., Qin, J., & Akiyama, N. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00249 · Cited by 32
“Moreover, impairment of the mTEC-dependent tolerance might explain the relationship between myocarditis and autoimmunity (22).”
BackgroundImmune checkpoint inhibitor-associated myocarditis: a historical and comprehensive review
Jensen, G. L., Wang, X., Kuempel, J., Palaskas, N. L., Chen, Z., Yu, W., Chen, Y., Mohammad, H., Luo, W., & Chang, J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00687.2024 · Cited by 35
Metadata
- Authors
- Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V. S. R. K., Cornivelli, L., Raddassi, K., Matsui, T., Rosenzweig, A., Bronson, R. T., Smith, R., Fletcher, A. L., Turley, S. J., Wucherpfennig, K., Kyewski, B., & Lipes, M. A.
- Affiliations
- Joslin Diabetes Center (US)
- Harvard University (US)
- German Cancer Research Center (DE)
- Corresponding author
- Lipes, Myra A.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1561-1573
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069776
- OpenAlex
- W2102807926
- Semantic Scholar
- 390386d1ea9c282aa38a38b3f6bfa36ad69df7d0
- Cited by
- 228
- References
- 71
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 31 · 2023: 19 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 17 · 2018: 10 · 2017: 12 · 2016: 6 · 2015: 9 · 2014: 7 · 2013: 12 · 2012: 13
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Joslin Diabetes Center
- Deutsches Krebsforschungszentrum
- European Commission
- Deutsche Forschungsgemeinschaft (SFB405)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL077554, R01HL077554)
- National Institute of Allergy and Infectious Diseases (P01AI045757)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074500, DK074500, R01DK072090)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myocarditis, dilated cardiomyopathy, autoimmunity, MYH6, thymic tolerance, medullary thymic epithelial cells, CD4+ T cells, autoantigens, T cell tolerance, transgenic mice, heart failure
- MeSH terms
- Animals, Autoantigens, Base Sequence, Disease Models, Animal, Female, HLA-DQ Antigens, Humans, Immune Tolerance, Infant, Infant, Newborn, Male, Mice, Inbred C57BL, Mice, Transgenic, Myocarditis, Myocardium, Thymus Gland, CD4-Positive T-Lymphocytes, Autoimmunity, Mice, Inbred NOD, DNA Primers, Mice, Knockout, Myosin Heavy Chains, Cardiac Myosins, Ventricular Myosins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.